Nonalcoholic fatty liver. Nonalcoholic fatty liver disease (NAFLD)
Conditions
Interventions
Intervention 1: The intervention group consisted of 40 patients. Randomly placed in this group. 20 grams per day for 3 months receive olive oil. Diet and recommendations are presented separately for e
Treatment - Other
Treatment - Drugs
The intervention group consisted of 40 patients. Randomly placed in this group. 20 grams per day for 3 months receive olive oil. Diet and recommendations are presented separately for each person. The
The intervention group consisted of 40 patients. Randomly placed in this group. 20 grams per day for 3 months receive sunflower oil. Diet and recommendations are presented separately for each person.
Sponsors
Oil Version Factory
School feeding
Eligibility
Sex/Gender
All
Age
18 Years to 70 Years
Inclusion criteria
Inclusion criteria: Inclusion criteria: having NAFLD by medical diagnosis (using ultrasound); BMI = 25 and above; willingness to participate in the study, the absence of diabetes mellitus type 2;heart disease; cardiovascular and liver disease (cirrhosis, liver disease Alcohol, viral hepatitis, autoimmune hepatitis, primary biliary cirrhosis, biliary obstruction, liver damage induced by drugs hereditary Hemochromatosis, sclerosis cholangitis and antitrypsin deficiency of a-a-1);other serious diseases such as cancer; kidney failure and celiac disease, etc); lack of pregnancy ;lactation; lack of drugs that are causing fatty liver (methotrexate, tamoxifen, Valproate, etc.); avoiding the use of any type of lipid lowering agents (atorvastatin, lovastatin, pravastatin, etc.); fibrates (gemfibrozil, fenofibrate); lack of malnutrition; have no special diets such as vegan and vegetarian; not drinking alcohol and having over 18 years of age. Exclusion criteria: non-compliance with recommended diet for more than 15 days over 3 months; acute or infectious disease; hospitalization or in cases where the criteria mentioned is.
Exclusion criteria
Exclusion criteria:
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Insulin resistance index. Timepoint: The beginning and end of the study. Method of measurement: blood test.;TNF-Alpha. Timepoint: Before the intervention, after intervention. Method of measurement: blood test.;Oxidative stress index. Timepoint: Before the intervention, after intervention. Method of measurement: blood test. | — |
Secondary
| Measure | Time frame |
|---|---|
| BMI. Timepoint: Beginning of the study and end of each month. Method of measurement: Balance-Meter.;Changes in body composition (fat and muscle mass). Timepoint: Before the intervention, after the intervention. Method of measurement: BIA devices.;The degree of fatty liver. Timepoint: Before the intervention, after the intervention. Method of measurement: Ultrasound.;Waist Circomfrance. Timepoint: Beginning of the study and end of each month. Method of measurement: Meter.;Blood pressure. Timepoint: Beginning of the study and end of each month. Method of measurement: Barometr. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactDoctor M. Akhlaghi
Shiraz University Of Medical Sciences
Outcome results
None listed